Prevymis (letermovir) - Merck (MSD)
The role of CMV-specific cellular immunity in transplant recipients with letermovir prophylaxis: to be determined. (PubMed, Clin Infect Dis) - Dec 1, 2025 - No abstract available 
Journal • Transplantation
http://www.ncbi.nlm.nih.gov/pubmed/41321122
 
Martina Sester; Yoichiro Natori
 
Dec 1, 2025
 
Prev Next